Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,635,471
+$745,555 QoQ
Shares Held
3,031
-3.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
#1,965
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesapeake Wealth Management holds $12,931,041 across 7 Drug Manufacturers - General names. LLY ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
3,031 | $3,635,471 | |
| 2 | ABBV |
AbbVie Inc.
|
14,357 | $3,612,794 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,024 | $1,930,584 | |
| 4 | JNJ |
Johnson & Johnson
|
7,575 | $1,923,822 | |
| 5 | AMGN |
Amgen Inc
|
3,188 | $1,154,437 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,265 | $360,989 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,477 | $312,944 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,635,471 | 3,031 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,889,916 | 3,142 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $3,549,667 | 3,303 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,411,080 | 3,160 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,412,645 | 3,095 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,593,357 | 3,140 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,511,316 | 3,253 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $3,038,773 | 3,430 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,202,328 | 3,537 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,856,668 | 3,672 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,437,187 | 4,181 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,372,502 | 4,417 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $2,204,206 | 4,700 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,634,335 | 4,759 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $1,769,933 | 4,838 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $1,628,390 | 5,036 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $1,716,473 | 5,294 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,534,942 | 5,360 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,572,520 | 5,693 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,356,956 | 5,873 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,505,192 | 6,558 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,363,972 | 7,301 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,297,704 | 7,686 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,186,379 | 8,015 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,316,723 | 8,020 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,104,488 | 7,962 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||